CAMBRIDGE NUTRITIONAL SCIENCES PLC (CNSL) — Interim Results

Investor webinar replay

Replay transcript excerpt

Good afternoon, ladies and gentlemen, and welcome to the CAMBRIDGE NUTRITIONAL SCIENCES PLC interim results presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged and can be submitted at any time using the Q and A tab Before we begin, we'd like to submit the following poll. And if you give that your kind attention, I'm sure the company will be most grateful. I'd now like to hand over to Chair, Simon Douglas. Good afternoon. Good afternoon, everyone, and thank you for your time this afternoon. It's very much appreciated. As you know, this is a presentation to take you through some of the details of our half year results up to the September 30. The RNS was released this morning, but we can hope we we can add some value to you this afternoon through this presentation. Just by way of introduction, my name is Simon Douglas. I am the chair of Cambridge NUTRITIONAL SCIENCES, and I've had a wide ranging background in healthcare diagnostics and pharma and have been the chair since February 2021. With me, this person I'm sure that most of you know is our CEO, Jack Rule, and he has had a wide ranging experience in the health nutrition business and been with the company for many years and has led us through the last twelve, eighteen months and brought us to what I think is a very solid position that you'll hear about more today. Jack will do most of the talking today. He knows the business backwards. I will be available at the end for questions. So so, Jack, over to you. Thank you, Simon, and good afternoon, everybody. Welcome to the half year presentation for Cambridge Nutrition Sciences. And I'd like to take you through a brief introduction to the company, some key operational highlights, importantly, the financials...